OBJECTIVES: Heart transplantation in children after univentricular palliation is a technical challenge. As the national referral centre for heart transplantation in children, we review national trends in transplantation and describe technical innovations used in the current era.
INTRODUCTION
Despite improvements in the results of palliation for univentricular cardiac defects, the proportion of paediatric heart transplantations performed for failed univentricular circulations is increasing [1] . As more patients with previous complex repairs, such as the Norwood procedure, require transplantations, reconstructive techniques that may be used to prepare vascular structures for heart transplantation might be useful. Here, we describe our experience and reconstructive techniques that we found very useful in preparation for successful heart transplantation in patients with complex univentricular anatomy.
MATERIALS AND METHODS
The Royal Children's Hospital is the national referral centre for paediatric heart transplantation in Australia. All patients (n = 111) who underwent heart transplantation from January 1988 to January 2013 were retrospectively reviewed. Patients were divided into structural congenital heart disease (sCHD) and cardiomyopathy (CM) groups. sCHD patients were further subdivided into those with biventricular and with univentricular physiologies. Focus was made on the univentricular physiology subgroup.
After 2000, we started to apply advanced surgical preparation of the great vessels to facilitate transplantation. Advanced intraoperative surgical preparation is a strategy for complex surgical reconstruction in advance of arrival of the donor heart. These reconstructions require significant time and thus have to be thoroughly coordinated with the timing of heart procurement to minimize donor ischaemic time. During this period, we also began to coordinate retrieval of the donor heart with the progress of the reconstruction, in order to minimize ischaemic time.
Statistical analysis
We compared the all-cause 30-day, hospital and 1-year mortalities between univentricular sCHD and CM in each of the two eras ( January 1988 to December 1999 and January 2000 to December 2012) using a χ 2 test. To examine the effect of perioperative care and generic post-transplant care on mortality, we compared 30-day mortality for CM before and after 2000 using a χ 2 test. This was performed with Stata 13.0 (StataCorp, College Station, TX, USA).
RESULTS
In total, 112 transplantations were performed: 50 (45%) for sCHD, 61 (55%) for CM and 1 retransplantation in a patient who had previously been transplanted for sCHD. Univentricular anatomy made up 60% (30 of 50 patients) of sCHD. The percentage of patients with sCHD who had univentricular anatomy increased during our experience, from 50% (11 of 22 patients; 1988-94) and 54% (7 of 13 patients; 1995-2002) to 86% (12 of 14 patients; 2003-12) , to become the most common anatomical indication for transplantation among children with sCHD ( Fig. 1) . The characteristics of patients undergoing transplantation for failed single-ventricle palliation are presented in Table 1 .
Thirty-day mortality after transplantation for univentricular sCHD was 21% (3 of 14 patients) before 2000, but fell to 6% (1 of 16 patients) after 2000. Hospital and 1-year mortalities for sCHD were the same as 30-day mortality. There were 2 hospital deaths in the CM group, who died after 30 days, at Days 39 and 93 from intracerebral haemorrhage and bronchomalacia. Before 2000, there were 3 hospital mortalities in the univentricular sCHD group: acute rejection in 2 and sepsis in 1. After 2000, the single mortality was because of primary graft failure. This occurred in a patient who had not required any vascular reconstructions and received a donor heart with an ischaemic time of 5 h. After an initial cardiopulmonary bypass run of 3 h, the patient could not be weaned from the pump and despite a second bypass run of 2 h, the patient was supported with extracorporeal membrane oxygenation. In the postoperative period, the patient developed multiorgan failure and sepsis, and died on Day 18.
When 30-day mortality for univentricular patients was compared with CM, it was significantly higher before 2000 (21 vs 0%, 3/14 vs 0/20, P = 0.023) and not different after 2000 (8 vs 6%, 3/38 vs 1/16 patients, P = 0.852). To examine the effect of perioperative care and intensive care on hospital mortality, we compared 30-day mortality after transplantation for CM before 2000 (9%, 2 of 22 patients) and after 2000 (8%, 3 of 38 patients), and found no difference (P = 0.197).
Beyond simple pulmonary artery (PA) patch repair, no patient before 2000 underwent advanced reconstruction of the great vessels. After 2000, 12 of 16 (75%) patients with univentricular sCHD required reconstruction of the aortic arch, pulmonary arteries or systemic veins before transplantation in the fashions described below.
Intraoperative surgical reconstructive techniques
The anatomy, indications, reconstructions performed, time to perform reconstructions and outcomes are given in Table 2 . The donor ischaemic times are also provided. Later in the series, some patients had donor ischaemic times of <2 h (Patients 14 and 16); however, longer ischaemic times still occurred when the donor heart was procured from interstate (Patients 11 and 15). Reconstructions fell into three categories: reconstruction of (i) systemic outflow (aortic arch) in 3 patients, (ii) systemic inflow (venae cava or innominate vein) in 3 patients and (iii) pulmonary arteries in 12 patients.
All 3 patients who required aortic arch reconstruction had previously undergone the Norwood procedure as neonates. In 1 patient, who was supported with a Berlin Heart left ventricular assist device at the time of transplantation, it was not possible to cross-clamp the aorta between the outflow cannula and the innominate artery, so an open arch reconstruction was carried out under deep hypothermic circulatory arrest using a 24-mm Dacron graft (InterVascular, France). The PA was reconstructed from hilum to hilum with a GoreTex patch (W. L. Gore & Associates, Arizona). The second patient had an aneurysm of the previously reconstructed arch ( Fig. 2A) . The aneurysm was densely adherent to the previously stented left PA. The aortic arch and both central PAs were resected (Fig. 2B) . The aortic arch was reconstructed under deep hypothermic circulatory arrest with an 18-mm Gelweave prosthesis (Vascutek, Terumo, UK) ( Fig. 2C 1 ), and the PA was then reconstructed with a GoreTex graft (Fig. 2C 2 ) . In the final patient, arch reconstruction was required because of a severely calcified homograft patch that was previously used to reconstruct the aortic arch. This patient's arch was replaced with the aortic arch of the donor. This patient also had a stent in the left PA that necessitated resection of the central PAs and reconstruction with a GoreTex patch. Thus, PA reconstruction from hilum to hilum was required in all 3 patients who underwent aortic arch reconstruction.
Similarly, PA reconstruction from hilum to hilum was performed in 2 additional patients. In 1 patient, the PAs were replaced from hilum to hilum using a GoreTex graft and in the other, the donor central PAs were anastomosed to the branch PAs within each hilum.
In the remaining 7 patients, the PA reconstructions consisted of patch repair of the site of the superior vena cava (SVC) to PA anastomosis in 5 patients (using pericardium in 3, donor aorta in 1 and GoreTex in 1) and reconstruction of the central PAs using the donor bifurcation in 2 patients.
All patients who required systemic venous reconstructions (n = 3) had left atrial isomerism with hemiazygos continuation of the inferior vena cava. Two of them had previously undergone the Kawashima procedure. The innominate vein was anastomosed to the donor SVC directly in 1 patient (Fig. 2C 3.1 ) , using a GoreTex tube in 1 (Fig. 2C 3. 2 ) and also using the recipient's PA as a conduit in 1 (Fig. 3) .
Non-technical considerations in univentricular structural congenital heart disease Beyond routine cardiopulmonary bypass, all 3 patients undergoing aortic arch reconstruction required modified cardiopulmonary bypass considerations. In only 1 of the 3 was selective cerebral perfusion used, while 2 required deep hypothermic circulatory arrest. Additionally, bypass time was prolonged in 2 patients in our experience because of the use of plasmapheresis for the presence of panel-reactive antibodies (PRAs).
Immediately prior to transplantation, 5 of 16 (31%) patients required circulatory support: 4 were admitted to the intensive care unit on inotropes, and 1 was supported with a ventricular assist device. At the conclusion of the transplant procedure, 2 patients required ECMO support. Overt bleeding disorders were not detected preoperatively in any patients, although coagulopathy or anastomotic bleeding requiring massive transfusion was troublesome in 3 (12%) patients, one of whom experienced significant haemoptysis during weaning from bypass.
DISCUSSION
Transplantation after failed univentricular palliation is becoming more frequent and more challenging as patients live longer and complex lesions like hypoplastic left heart syndrome (HLHS) are successfully surgically palliated [1, 2] . In our experience, the two most important aspects that represent the biggest challenges when performing transplantation in this population are (i) anatomical reconstruction of vessels prior to transplantation and (ii) reduction of donor heart ischaemic time by accurate timing of heart retrieval according to the progress of the surgical preparation of the recipient. Table 3 summarizes the unique problems encountered in transplantation for failed single-ventricle palliation, and some of the solutions we used or recommend. Univentricular palliation, particularly prior Fontan operation, has been identified as a risk factor for worse outcomes after heart transplantation [3] [4] [5] . The worse outcomes are due, in large part, to the surgical complexity of heart transplantation into recipients with prior multiple cardiac surgeries. Other problems of the failing univentricular circulation also contribute to increased perioperative risk, such as protein-losing enteropathy, pulmonary vascular malformations, elevated pulmonary vascular resistance, as well as a tendency towards bleeding and infection [6] . Finally, patients who have had multiple prior operations are more likely to have high PRA titres, and this may have historically caused worse results among univentricular patients. As a result, operative mortality was initially 29-44% in the 1990s [4, 7, 8] in this group. The initial reports from this era, which described surgically creative techniques to enable transplantation, were in an era when palliative procedures occurred only at an atrial or pulmonary arterial level [7, 9, 10] . Results were poor despite the simplicity of reconstructions required.
In the current era, patients are far more complex. The Norwood procedure for HLHS is now widely performed. There is often a need to augment pulmonary arteries to enable successful single-ventricle palliation. Thus, more technically demanding reconstructions are often required at the time of transplantation. Despite the greater complexities, our contemporary series and those of Kanter et al. [11] and Murtuza et al. [12] show that ongoing surgical innovation may result in operative mortality of <10%. The study by Kanter et al. on 27 patients under 18 years of age at a single centre was the first to demonstrate that prior Fontan palliation was no longer a risk factor for mortality. They attributed this to careful patient selection as reflected in the small percentage of patients in their series with a Fontan circulation (14%). Furthermore, the levels of pre-sensitization with PRAs were no different in their series, as patients with presensitization were more likely to die while waiting for a suitably matched heart. Finally, their institution had a liberal policy for retransplantation: among 27 Fontan patients, 5 (18%) received a second transplantation. Murtuza et al. [12] recently reported the results of transplantation in 16 surgically palliated patients with HLHS (10 at the stage of bidirectional cavopulmonary shunt [BCPS], 4 Fontan, 1 Kawashima and 1 Norwood) without operative mortalities and achieved 1-and 5-year survivals that were comparable with the CM control group. In our series, the only hospital and 1-year mortality after 2000 was in a patient who did not have any reconstructions performed and died of primary graft failure. Our series features a high percentage of Fontan patients in the later era (8 of 16 patients, 50%) and demonstrates hospital and 1-year survival that is comparable with North American experiences.
Focusing on the reconstructive techniques used in the contemporary era, we demonstrated how reconstructions at all levels (venous drainage, pulmonary outflow and systemic outflow) might facilitate successful transplantation. No matter how high the quality of perioperative care or donor organ preservation might have been, without the techniques described here, successful transplantation would not have been possible in some of our patients. The time taken for each reconstruction is considerable. For example, 3 of the 5 patients with HLHS required reconstruction of the aortic arch, often with deep hypothermic circulatory arrest. The avoidance of excessively long donor ischaemic times was possible by taking into account the reconstructive time when planning and coordinating donor retrieval. Our series emphasizes the value of pretransplantation surgical preparation using prosthetic tissue, in order to minimize the ischaemic time of the donor heart.
Looking to the future, concomitant liver failure in patients entering the fourth and fifth decades of univentricular physiology has led other teams to describe the technique of heart-liver transplantation [13] . This adds yet another level of complexity to transplantation in this already challenging group of patients. Surgeons performing heart transplantation in patients with failed univentricular palliations must thus have an extensive experience in the treatment of congenital heart disease and expertise with reconstructive techniques at their disposal.
Our study shows that the prevalence and anatomy of transplantation in the context of sCHD, particularly with respect to single-ventricle palliation, has changed in the last decade. In addition, it shows that in order to transplant the donor heart in such complex patients, complex anatomical repairs of the great vessels are needed because of the sequelae of prior palliations.
LIMITATIONS
The study is limited by its retrospective nature. Any associations between the surgical reconstructions used and reductions in mortality do not prove causation, as causation can only be determined through a prospective study. Non-technical factors may have contributed to the reduction in mortality seen in this study.
CONCLUSIONS
The increasing complexity of transplantation after failed singleventricle palliation necessitates techniques to reconstruct the aorta, pulmonary arteries and systemic veins to permit successful transplantation. Advanced surgical preparation may have a role in reconstruction of the great vessels before transplantation to minimize donor ischaemia times. For example, in this group of patients, we tend to oversize the donor heart because we believe pulmonary vascular resistance may have increased. And the second thing I would like to know is whether you have noticed changes, for example, in your warm ischaemic time, which, as you know, is very important in transplantation, even more than the complete total ischaemic time.
Then, considering patient selection in terms of how we're looking after the patient before surgery: some of these patients are kept in the hospital nowadays on milrinone, and some on ventilators to optimize the end organ function. Not forgetting what's happening after transplant, nowadays we have a more refined technique to support these patients to prevent early signs of acute graft failure or acute rejection with or without mechanical cardiac support.
So I would like you to elaborate a little bit on these other factors which are important and may have improved your results.
Dr Iyengar: I agree with you and I believe that all those factors have certainly played a role, and that includes the postoperative care of the patients. In terms of warm ischaemic time, we didn't study that, but we've maintained an attitude of trying to minimize warm ischaemic time to about 60 minutes for most of the series. As for patient selection, I can't comment on that based on this series, but I might get Yves to.
Dr Y. d'Udekem (Melbourne, Australia): Regarding patient selection, I'm afraid we cannot be too choosy because the donor rate in Australia is half that of the Western world, half that of Europe and North America: So our waiting list is twice as long than in the rest of the world, and we cannot be very picky in terms of donors.
But we are not picky in terms of size, and we still remain quite selective in terms of the quality of the donor. We will not accept a donor above 50 years of age, and we like the patients to be in good condition, and we have a very low threshold to eliminate any comorbidities and cardiovascular risk.
We have no particular management in this patient group. The thing that has arisen in recent years is that we have more and more patients with very high PRA levels, and we have to do a plasma exchange in them. Our strategy is to bring the patient to the theatre, to go on cardiopulmonary bypass and perform the plasma exchange on bypass. And we know it takes about 45 minutes to one hour to do a complete plasmapheresis in these patients before we get the donor heart here, and then we can do the reconstruction at the same time. 
